Skip to content
Yog Pharma
CardiovascularCalcium channel blocker (dihydropyridine)

Amlodipine Besylate is a calcium channel blocker (dihydropyridine) indicated for hypertension, chronic stable angina and vasospastic angina. We supply it to US manufacturers of tablets, oral suspension and fixed-dose combinations.

CAS111470-99-6567.1 g/molC26H31ClN2O8S
2D structure of Amlodipine Besylate, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 60496) and FDA’s substance registry

CAS number

111470-99-6

Molecular formula

C26H31ClN2O8S

Molecular weight

567.1g/mol

FDA UNII

IUPAC name

benzenesulfonic acid;3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

InChIKey

ZPBWCRDSRKPIDG-UHFFFAOYSA-N

Appearance
White crystalline powder.
Solubility
Slightly soluble in water and sparingly soluble in ethanol.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

Sensitive to light, so packaging and storage conditions belong in the specification. Strengths are expressed as amlodipine base: about 6.9 mg of the besylate salt delivers 5 mg.

On the US market

Reference product
NorvascNDA 019787
Approved ANDAs
19 with a marketed product
Approved forms and strengths
  • Tablet 2.5 mg, 5 mg, 10 mg
  • Powder for oral solution 2.5 mg per bottle, 5 mg per bottle, 10 mg per bottle
  • Oral solution 1 mg/mL

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com